Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

This Under-the-Radar Growth Stock Could Soar by 277%, According to Wall Street

TheMotleyFool

0 0

This Under-the-Radar Growth Stock Could Soar by 277%, According to Wall Street: https://g.foolcdn.com/editorial/images/744354/growth-curve.jpg

If you're looking for a hidden gem in the biotech sector, you might want to check out Stoke Therapeutics (NASDAQ: STOK). This company is developing innovative therapies for rare genetic diseases that represent a high degree of unmet medical need.

And according to Wall Street analysts, the small-cap biotech has the potential to deliver a staggering 277% return over the next 12 months.

Image source: Getty Images.

Source Fool.com

Like: 0

STOK

Share